Myriad Genetics Inc
F:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
B
|
Bank of Nova Scotia
XMUN:BKN
|
CA |
|
P
|
Petroleo Brasileiro SA Petrobras
XBER:PJX
|
BR |
|
A
|
Aemetis Inc
F:DW51
|
US |
|
Brightspire Capital Inc
F:41W0
|
US |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
B
|
BWX Technologies Inc
F:4BW
|
US |
|
J
|
JD.Com Inc
VSE:JD
|
CN |
|
E
|
Elite Express Holding Inc
NASDAQ:ETS
|
US |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for MYD is 7.82 EUR with a low forecast of 4.765 EUR and a high forecast of 12.385 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
7.82
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 7.82 EUR with a low forecast of 4.765 EUR and a high forecast of 12.385 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
8%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 8%.
